• Science and Research

  Orkambi Benefits CF Patients But Risks Evident in Those Who Can’t Tolerate It, French Study Finds

  Posted by cystic-fibrosis-news-moderator on October 30, 2019 at 10:24 am

  

  A study of Orkambi’s use in 845 CF patients found definite lung and weight benefits among those who could use Orkambi, but that 18% had to stop treatment. Read more about this study here.

  What do you think of this trial and its findings?

  cystic-fibrosis-news-moderator replied 4 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply